Hospital Pharmacy Compounding against COVID-19 pandemic.

Hospital Pharmacy Compounding against COVID-19 pandemic.

Carme Cañete Ramírez, José María Alonso Herreros, Ana María Martín de Rosales Cabrera, Carmen López-Cabezas, Beatriz Ramos-Martínez, Silvia Berisa-Prado, Carmen Dávila-Pousa, María Del Pilar Flox-Benítez, Margarita Ladrón de Guevara-García

As in other areas of the health system, COVID-19 has had a dramatic impact on  hospital compounding. This area has faced numerous challenges, including the  shortage of frequent-use products (hydroalcoholic solutions, lopinavir/ritonavir  suspension), the use of new preparations for SARS-CoV-2 (tocilizumab,  remdesivir), or requests from overwhelmed wards unable to assume the safe  preparation of a high volume of medications (intravenous solutions). The  demand for all types of preparations (topic and oral medications, intravenous  solutions) has increased dramatically. This increase has highlighted the shortage of resources allocated to this area, which has made it difficult to meet the high  demand for preparations. In addition, the pandemic has revealed the scarcity of  research on such basic aspects as agent stability and drug compatibility. One of  the most relevant conclusions drawn from the COVID-19 pandemic is that the  basic areas of hospital pharmacy, along with other, must be maintained and  reinforced, as these are the areas that make us essential.

2020

DOI: 10.7399/fh.11492

Farmacia Hospitalaria

Grupo Aula Médica